Sibutramine Hydrochloride Patent Expiration
Sibutramine Hydrochloride is Used for weight loss in individuals with obesity. It was first introduced by Abbott Laboratories Pharmaceutical Products Div
Sibutramine Hydrochloride Patents
Given below is the list of patents protecting Sibutramine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Meridia |
US5436272 (Pediatric) | Treatment of obesity |
Jan 25, 2013
(Expired) | Abbott |
| Meridia | US5436272 | Treatment of obesity |
Jul 25, 2012
(Expired) | Abbott |
Sibutramine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List